A Randomized Trial of Exemestane after Two to Three Years of Tamoxifen Therapy in Postmenopausal Women with Primary Breast Cancer-Reference-Cited by-同舟云学术

A Randomized Trial of Exemestane after Two to Three Years of Tamoxifen Therapy in Postmenopausal Women with Primary Breast Cancer

Published:2004-03-11 Issue:11 Volume:350 Page:1081-1092
ISSN:0028-4793
Container-title:New England Journal of Medicine
language:en
Short-container-title:N Engl J Med

Author:

Coombes R. Charles,Hall Emma,Gibson Lorna J.,Paridaens Robert,Jassem Jacek,Delozier Thierry,Jones Stephen E.,Alvarez Isabel,Bertelli Gianfilippo,Ortmann Olaf,Coates Alan S.,Bajetta Emilio,Dodwell David,Coleman Robert E.,Fallowfield Lesley J.,Mickiewicz Elizabeth,Andersen Jorn,Lønning Per E.,Cocconi Giorgio,Stewart Alan,Stuart Nick,Snowdon Claire F.,Carpentieri Marina,Massimini Giorgio,Bliss Judith M.

Publisher

Massachusetts Medical Society

Subject

General Medicine

Link

http://www.nejm.org/doi/pdf/10.1056/NEJMoa040331

Cited by 1545 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Breast Cancer;International Encyclopedia of Public Health;2025

2. Prognostic impact of selection criteria of current adjuvant endocrine therapy trials NATALEE and monarchE in postmenopausal HRpos/HER2neg breast cancer patients treated with upfront letrozole;European Journal of Cancer;2024-09

3. Managing sexual health challenges in breast cancer survivors: A comprehensive review;The Breast;2024-08

4. Breast Cancer, Version 3.2024, NCCN Clinical Practice Guidelines in Oncology;Journal of the National Comprehensive Cancer Network;2024-07

5. Long-term Follow-up and Safety of Patients after an Upfront Therapy with Letrozole for Early Breast Cancer in Routine Clinical Care – The PreFace Study;Senologie - Zeitschrift für Mammadiagnostik und -therapie;2024-05-23